Breast Cancer

Generex Biotechnology establishes CRADA

Published in Cancer Weekly, October 26th, 2004

Generex Biotechnology Corp. (GNBT) announced that its wholly owned subsidiary, Antigen Express, has entered into a collaborative research and development agreement (CRADA) with the Uniformed Services University of the Health Sciences (USU) and The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., to work with LTC George Peoples, MD, Medical Corps, U.S. Army, to advance HER-2/neu vaccine efforts for breast cancer.

Peoples is assigned to the Walter Reed Army Medical Center (WRAMC) and works in conjunction with the Clinical Breast Care Project (CBCP). The CBCP is a congressionally mandated civilian-military collaboration between WRAMC, USU, the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-10-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry